Notes / Company

Genpharmasec Ltd.

GENPHARMA BSE 531592 ISIN INE861N01036 Dyes & Pigments

Fundamentals

Market cap: ₹67 cr
P/E: 42.21×
ROE: 1.92%
Debt / equity: 0.05
52-week range: 0.75 — 2.33

Research on Tijori Finance

The timeline — 2 notes on Genpharmasec Ltd.

May 2026

21 May 26 · 17:36 IST Brief

Brief · Earnings

Genpharmasec revenue surges 4x, consolidated profit slips to ₹56.01 lakh

Standalone revenue jumped to ₹13,134.94 lakh from ₹3,296.07 lakh, but two loss-making subsidiaries dragged consolidated profit to just ₹56.01 lakh, with auditor flagging going-concern uncertainties.
21 May 26 · 17:28 IST Brief

Brief · Earnings

Genpharmasec revenue quadruples but two subsidiaries bleed

Standalone sales hit ₹131 cr, aided by the Derren Healthcare acquisition. Auditor flags going concern doubts on two units despite parent's support.

Verify on exchange BSE filings for GENPHARMA NSE filings for GENPHARMA Tijori Finance company page